K8凯发

  • 6687ac98b5470
    Cancel
    Date：2024-07
    /index.php?a=shows&catid=34&id=839

    MoonBiotech announced that it has recently completed a RMB 300 million Series C+ financing, solely invested by SDIC JULI Investment Management Co., LTD. This financing round follows the Series C funding involving SDIC Venture Capital, marking another inst

  • 66580d7c774ac
    Cancel
    Date：2024-05
    /index.php?a=shows&catid=34&id=775

    Recently, Blue Sail Medical (002382.SZ) announced that its cardiovascular and cerebrovascular business unit, Blue Sail Biosensors, has raised a total of RMB 1 billion in funding. The Series A2 round introduced an additional RMB 100 million, following a RM

  • 66554c4f539d0
    Cancel
    Date：2024-05

    Exclusive Financial Advisor to MagAssist

  • 66554b11a633b
    Cancel
    Date：2024-05
    /index.php?a=shows&catid=34&id=773

    Recently, Vision Medicals announced a successful completion of D+ round funding worth hundreds of millions RMB, with Kequan Fund as lead-investor and Tianxin Fund as co-investor. Funds raised in this round will be primarily used to promote the research an

  • 67340c2ff1eb3
    Cancel
    Date：2024-03

    Exclusive Financial Advisor to HYGIEIA

  • 66051502bfab9
    Cancel
    Date：2024-03
    /index.php?a=shows&catid=34&id=772

    Recently, InfiMotion announced the completion of hundreds of millions of yuan in Series A funding. The round was led by the National Adjustment Fund, with participation from Wuxi New Energy Industry Fund, Huiheng Industry, Huishan Financial Services, and

  • 65e691a3a2888
    Cancel
    Date：2024-02
    /index.php?a=shows&catid=34&id=771

    On February 21, 2024, Yantai Dongcheng Biochemicals (002675) announced that its wholly-owned subsidiary, Yitai Pharmaceutical, intends to purchase the 99mTc-GSA injection and GSA cold kit (hereinafter referred to as the "target product") held by Rongcheng

  • 65fcfdae86f56
    Cancel
    Date：2024-02
    /index.php?a=shows&catid=34&id=770

    Today, Affection Animal Pharmaceuticals successfully completed a Series C funding round worth hundreds of millions of yuan. This equity financing was co-led by Yuanxi Haihe Fund and Songqing Shenhui Jiarui Private Investment Fund, with Guohai Innovation C

  • 659cdfe806117
    Cancel
    Date：2024-01
    /index.php?a=shows&catid=34&id=768

    On January 8, 2024, Rokid officially signed the "Lingban Smart Investment Cooperation Agreement" with the Hefei Municipal Government. The two parties will collaborate on the development of the metaverse industry and engage in deep cooperation. Simultaneou


【网站地图】